HSA
- Marketing authorisation holder: SYNDAX
- Status: likely_approved
🇸🇬 Revuforj in Singapore
Revuforj (REVUMENIB) regulatory status in Singapore.
Marketing authorisation
Revuforj in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Singapore
Frequently asked questions
Is Revuforj approved in Singapore?
Yes. HSA has authorised it.
Who is the marketing authorisation holder for Revuforj in Singapore?
SYNDAX holds the Singaporean marketing authorisation.